Medical abortions no more dangerous than surgical abortions

Article

Medical abortions using misoprostol with or without mifepristone are no more likely than surgical abortions to increase the risk of spontaneous abortion, ectopic pregnancy, preterm birth, or low birthweight in subsequent pregnancies, researchers report in the Aug. 16 issue of the New England Journal of Medicine.

Medical abortions using misoprostol with or without mifepristone are no more likely than surgical abortions to increase the risk of spontaneous abortion, ectopic pregnancy, preterm birth, or low birthweight in subsequent pregnancies, researchers report in the Aug. 16 issue of the New England Journal of Medicine.

Jasveer Virk, MS, MPH, of the University of California Los Angeles, and colleagues conducted a cohort study of 11,814 Danish women who had undergone a first-trimester abortion followed by at least one subsequent pregnancy. Researchers compared the risks of pregnancy complications in women who underwent medical abortion compared to those who had a surgical abortion.

Overall, 2,710 women had medical abortions and 9,104 had surgical abortions. After controlling for maternal age, interval between pregnancies, and other demographic factors, medical abortion was not associated with an increased risk compared to surgical abortion in any of the variables evaluated (ectopic pregnancy, spontaneous abortion, preterm birth or low birthweight).

Virk J, Zhang J, Olsen J. Medical abortion and the risk of subsequent adverse pregnancy outcomes. N Engl J Med. 2007;357:648-653.

Recent Videos
Lauren Streicher, MD
March of Dimes reports increase in maternity care desert prevalence | Image Credit: marchofdimes.org.
Evaluating a miniature robotic device for hysterectomy | Image Credit: linkedin.com.
Discussing low-dose aspirin use for preeclampsia prevention | Image Credit: komodohealth.com
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Related Content
© 2024 MJH Life Sciences

All rights reserved.